2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH DENA BATTLE
Patient Perspectives on Cytoreductive Nephrectomy after the CARMENA Trial

VIEW ALL ASCO GU 2019 VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH OLIVER SARTOR
Overall Survival Benefit and Racial Disparities in African American Men with Metastatic Prostate Cancer

VIEW ALL PCF VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH KARIM FIZAZI
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH JAMES GULLEY
Immunotherapy Across Genitourinary Malignancies

VIEW ALL ASCO GU 2019 VIDEOS

Featured Videos

AUGS/IUGA 2014 - Poster: Burden on secondary care of overactive bladder patients who are inadequately managed with anticholinergics in England

WASHINGTON, DC USA (UroToday.com) - Presented by Rizwan Hamid,1 Clara Loveman,2 Rick H. Morton,2 Jim S. Millen,2 and Yasir Hassan3 at the American Urogynecologic Society (AUGS) and the International Urogynecological Association (IUGA) Joint Scientific Meetings - July 22 - 26, 2014 - Washington, DC USA

augs-iuga2014 burden refractory oab thumb

1Royal National Orthopaedic Hospital & University College Hospital, London, England, United Kingdom;
2Allergan Holdings Ltd., Marlow, England, United Kingdom;
3Health iQ, London, England, United Kingdom

 

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 3 Issue 4

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe